Drawing based on the label description. No photo yet.
“Letrozole tablets USP, 2.5 mg are dark yellow coloured, round, biconvex, film coated tablets with 'LET' debossed on one side and '2.5' on other side”
LET 2 5 pill
Pill with imprint LET 2 5 is yellow, round, 6 mm and has been identified as Letrozole 2.5 mg. It is used for breast cancer. It is supplied by Dr. Reddy's Laboratories Limited.
Letrozole 2.5 mg
- Imprint
- LET 2 5
- Strength
- 2.5 mg
- Used for
- Breast cancer
- Color
- Yellow
- Shape
- Round
- Size
- 6 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Dr. Reddy's Laboratories Limited
- Drug class
- Breast cancer medicine (aromatase inhibitor)
- NDC
- 55111-646, 55111-646-30, 55111-646-79, 55111-646-78
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Letrozole used for?
Letrozole is used for breast cancer.
- Medicine type
- Breast cancer medicine (aromatase inhibitor)
Official uses from the US prescribing label
Adjuvant Treatment of Early Breast Cancer
Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
Extended Adjuvant Treatment of Early Breast Cancer
Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.
First and Second-Line Treatment of Advanced Breast Cancer
Letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. Letrozole tablets are also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
From the FDA-approved label on DailyMed (published Aug 21, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows LET and the other side shows 2.5.
- It is yellow, round, 6 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Letrozole
Inactive: Silicon Dioxide, Croscarmellose Sodium, Hypromelloses, Lactose Monohydrate, Magnesium Stearate, Polyethylene Glycol, Unspecified, Povidone, Talc, Titanium Dioxide, Ferric Oxide Yellow
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AN 247
Chlorthalidone 25 mg
Yellow, round, 6 mm
Used for high blood pressure and heart failure
-
J 5
Prochlorperazine Maleate 5 mg
Yellow, round, 7 mm
Used for anxiety and schizophrenia
-
AN899 15
Aripiprazole 15 mg
Yellow, round, 6 mm
Used for schizophrenia
-
C
Olmesartan Medoxomil 5 mg
Yellow, round, 5 mm
Used for high blood pressure and heart failure
-
497
Zolmitriptan 2.5 mg
Yellow, round, 7 mm
Used for migraine
-
G 51
Solifenacin Succinate 5 mg
Yellow, round, 6 mm
Used for overactive bladder
Other Letrozole pills
- M L71 Letrozole 2.5 mg Pink, round, 6 mm Used for breast cancer
- FV CG Letrozole 2.5 mg Yellow, round, 7 mm Used for breast cancer
- TEVA B1 Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- WW 74 Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- N L Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- LT Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- L2 5 Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- 121 YL Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer